"Peter J. Hotez and Maria Elena Bottazzi began development on the vaccine, known as CORBEVAX, in 2020 and currently are awaiting the final results of Phase Three clinical trials to determine its efficacy rate with respect to the Omicron COVID-19 variant.

In sharp contrast to the four dominant vaccines globally, CORBEVAX is protected by no patents or other intellectual property protection."

#RachelThrasher

https://www.bu.edu/gdp/2022/02/06/open-source-covid-19-vaccine-offers-potential-pathway-for-vaccinating-the-world/

#COVID #vaccines #CORBEVAX #DrugPatents

big things…”—Hotez, HERO!

Meanwhile, Moderna anticipates pricing their vaccine at $130. Highway robbery — more evidence of Big Pharma’s continued exploitation of US consumers.
https://reut.rs/3n7IcqX

https://publishingperspectives.com/2021/12/author-peter-hotezs-vaccine-corbevax-authorized-in-india-covid19/

#Vaccine #corbevax #COVID #COVIDVaccine #medicine

@tanyatussing @DeanBaker13
Thanks for sharing that important article. It shows #BigPharma greed, in this case with respect to yet another essential life-saving treatment, #CovidVaccine

I also need to express my admiration for Drs Hotez and Bottazzi who developed #Corbevax and made it open source.

கோர்பேவாக்ஸ் பூஸ்டர் தடுப்பூசி போடும் பணியை தொடங்கி வைத்தார் அமைச்சர் மா.சுப்பிரமணியன்… https://patrikai.com/minister-ma-subramanian-launched-corbevax-booster-vaccination/ via @patrikaidotcom@twitter.com

#Corbevax #boosterdose #Booster #vaccine @Subramanian_ma@twitter.com

5-12 வயதிற்குட்பட்டவர்களுக்கு அவசரகால பயன்பாட்டுக்கு Corbevax தடுப்பூசி அங்கீகரிக்கப்பட்டுள்ளது https://patrikai.com/corbevax-vaccine-is-approved-for-emergency-use-in-children-5-12-years-of-age/ via @patrikaidotcom@twitter.com

#Corbevax #DGCI #vaccine @MoHFW_INDIA@twitter.com

3/ #Corbevax ist wirksam, günstig & einfach in der Herstellung und Lagerung.
Ziel seiner Erfinder*innen ist nicht Profitmaximierung, sondern dass alle Länder sicheren Impfstoff in großen Mengen produzieren können - ganz ohne Patente & künstliche Hürden 👑
#PatenteFreigeben

1/ Von Anfang an war klar: die Corona-Pandemie endet erst dann, wenn ein Großteil der Welt geimpft ist.
Vielleicht sind wir diesem Ziel jetzt ein Stück näher, denn ein Team aus Texas hat den patentfreien Impfstoff #Corbevax entwickelt: https://www.theguardian.com/us-news/2022/jan/15/corbevax-covid-vaccine-texas-scientists

The first vaccine to battle global inequity

At this point in the pandemic, 9.21 billion doses have been administered globally, with 58% of the global population having received at least one dose of a COVID-19 vaccine. Only 8.5% of people in low-income countries have been vaccinated.

https://www.advancedsciencenews.com/corbevax-vaccine-offers-solution-to-global-vaccine-inequity/ #covid19 #corbevax